Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.72 USD | -3.55% | -4.56% | -33.50% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
Financials (USD)
Sales 2024 * | 456M | Sales 2025 * | 477M | Capitalization | 374M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 7M | EV / Sales 2024 * | 0.8 x |
Net cash position 2024 * | 9.83M | Net cash position 2025 * | 24.56M | EV / Sales 2025 * | 0.73 x |
P/E ratio 2024 * |
-282
x | P/E ratio 2025 * |
52.9
x | Employees | 862 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.51% |
Latest transcript on Organogenesis Holdings Inc.
1 day | -3.01% | ||
1 week | -4.04% | ||
Current month | +16.38% | ||
1 month | -8.22% | ||
3 months | -20.95% | ||
6 months | +3.21% | ||
Current year | -33.13% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Gillheeney
CEO | Chief Executive Officer | 69 | 13-12-31 |
David Francisco
DFI | Director of Finance/CFO | 59 | 21-02-15 |
Patrick Bilbo
COO | Chief Operating Officer | 63 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Nussdorf
BRD | Director/Board Member | 70 | 02-12-31 |
Alan Ades
BRD | Director/Board Member | 86 | 02-12-31 |
Michael Driscoll
BRD | Director/Board Member | 63 | 22-02-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 25 M€ | -1.67% | - | |
0.09% | 28 M€ | -1.09% | ||
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 2.725 | -3.37% | 66 273 |
24-05-22 | 2.82 | +1.81% | 415,063 |
24-05-21 | 2.77 | 0.00% | 402,966 |
24-05-20 | 2.77 | +1.09% | 385,433 |
24-05-17 | 2.74 | -3.86% | 483,387 |
Delayed Quote Nasdaq, May 23, 2024 at 10:27 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.13% | 374M | |
+62.52% | 62.59B | |
-2.42% | 41.18B | |
+44.36% | 40.29B | |
-8.29% | 27.9B | |
+12.27% | 26.21B | |
-21.66% | 19.09B | |
+5.22% | 13.08B | |
+24.69% | 12.26B | |
+28.10% | 12.05B |
- Stock Market
- Equities
- ORGO Stock